Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
Aim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of t...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2023-02-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3332 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839577747277479936 |
---|---|
author | A. A. Gurkina N. I. Stuklov N. D. Kisly R. R. Gimadiev M. S. Kovalchuk |
author_facet | A. A. Gurkina N. I. Stuklov N. D. Kisly R. R. Gimadiev M. S. Kovalchuk |
author_sort | A. A. Gurkina |
collection | DOAJ |
description | Aim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of the general group were divided into 3 subgroups depending on the serum ferritin (SF) and transferrin saturation (TS).Results. Anemia in HF is not always associated with iron deficiency (ID), characterized by inadequate production of erythropoietin, increased levels of C-reactive protein and hepcidin. From the general group of patients, the following were distinguished: absolute ID (43%), functional ID (19%), and non-ID anemia (38%).Conclusion. In the general group of patients with HF, anemia is normochromic, normocytic, characterized by high levels of C-reactive protein, hepcidin, and inadequate production of erythropoietin. Patients with absolute and functional ID do not differ in the main iron metabolism parameters and in general account for 62% (p=0,01). In these two subgroups, iron supplements should be prescribed at further stages. |
format | Article |
id | doaj-art-0d955b7c4d5c444d99c7cc4be41ddaf6 |
institution | Matheson Library |
issn | 1728-8800 2619-0125 |
language | Russian |
publishDate | 2023-02-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj-art-0d955b7c4d5c444d99c7cc4be41ddaf62025-08-04T12:50:29Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252023-02-0122110.15829/1728-8800-2023-33322627Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammationA. A. Gurkina0N. I. Stuklov1N. D. Kisly2R. R. Gimadiev3M. S. Kovalchuk4Peoples’ Friendship University of RussiaPeoples’ Friendship University of Russia; National Medical Research Center of RadiologyPeoples’ Friendship University of RussiaPeoples’ Friendship University of Russia; Eurotest, OOOPeoples’ Friendship University of RussiaAim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of the general group were divided into 3 subgroups depending on the serum ferritin (SF) and transferrin saturation (TS).Results. Anemia in HF is not always associated with iron deficiency (ID), characterized by inadequate production of erythropoietin, increased levels of C-reactive protein and hepcidin. From the general group of patients, the following were distinguished: absolute ID (43%), functional ID (19%), and non-ID anemia (38%).Conclusion. In the general group of patients with HF, anemia is normochromic, normocytic, characterized by high levels of C-reactive protein, hepcidin, and inadequate production of erythropoietin. Patients with absolute and functional ID do not differ in the main iron metabolism parameters and in general account for 62% (p=0,01). In these two subgroups, iron supplements should be prescribed at further stages.https://cardiovascular.elpub.ru/jour/article/view/3332heart failureanemiairon deficiency syndromesferritinerythropoietinhepcidin |
spellingShingle | A. A. Gurkina N. I. Stuklov N. D. Kisly R. R. Gimadiev M. S. Kovalchuk Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation Кардиоваскулярная терапия и профилактика heart failure anemia iron deficiency syndromes ferritin erythropoietin hepcidin |
title | Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation |
title_full | Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation |
title_fullStr | Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation |
title_full_unstemmed | Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation |
title_short | Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation |
title_sort | characteristics of anemia in heart failure iron metabolism erythropoietic activity and markers of inflammation |
topic | heart failure anemia iron deficiency syndromes ferritin erythropoietin hepcidin |
url | https://cardiovascular.elpub.ru/jour/article/view/3332 |
work_keys_str_mv | AT aagurkina characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation AT nistuklov characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation AT ndkisly characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation AT rrgimadiev characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation AT mskovalchuk characteristicsofanemiainheartfailureironmetabolismerythropoieticactivityandmarkersofinflammation |